Compound class:
Synthetic organic
Comment: The discovery of compound 13d is reported in [1], a medicinal chemistry study to identify selective bone morphogenetic protein receptor (BMP) inhibitors. Compound 13d inhibits all of the Type I receptor serine/threonine kinases to a greater or lesser extent, but is most potent at ALK1 (ACVRL1) and ALK2 (ACVR1) which are activin receptor components, and ALK3 (BMPR1A) and ALK6 (BMPR1B) which are bone morphogenetic protein receptors.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
4-[4-(3-quinolin-4-ylpyrazolo[1,5-a]pyrimidin-6-yl)phenyl]morpholine |
Database Links | |
BindingDB Ligand | 50434752 |
ChEMBL Ligand | CHEMBL2385582 |
GtoPdb PubChem SID | 249565800 |
PubChem CID | 60182389 |
Search Google for chemical match using the InChIKey | SZVLDZCYMADNPG-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | SZVLDZCYMADNPG |
UniChem Compound Search for chemical match using the InChIKey | SZVLDZCYMADNPG-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SZVLDZCYMADNPG-UHFFFAOYSA-N |